Yukio Sekiguchi
Overview
Explore the profile of Yukio Sekiguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
1810
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shinohara T, Takagi M, Kamakura T, Komatsu Y, Aizawa Y, Sekiguchi Y, et al.
J Cardiovasc Electrophysiol
. 2024 Feb;
35(4):701-707.
PMID: 38329163
Introduction: Most patients with Brugada syndrome (BrS) are first diagnosed in their 40s, with sudden cardiac death (SCD) often occurring in their 50s. Ventricular fibrillation (VF) may occur in some...
12.
Fukunaga H, Sekiguchi Y, Sawaguchi J, Hayashi Y, Asano S, Mabuchi K, et al.
Int J Cardiol Heart Vasc
. 2024 Jan;
50:101326.
PMID: 38192687
Background: The POLARx FIT system (Boston Scientific, MA, USA) is a novel cryoballoon (CB) ablation technology in which the balloon diameter can be expanded from 28 to 31 mm. The...
13.
Ikenouchi T, Miyazaki S, Nitta J, Sekiguchi Y, Kobori A, Nakamura K, et al.
J Interv Card Electrophysiol
. 2023 Dec;
67(1):5-12.
PMID: 38087145
Background: Single-shot pulmonary vein isolation (PVI) utilizing cryothermal energy is an effective and safe treatment for atrial fibrillation (AF) patients. A novel cryoballoon system, POLARx™, has been recently introduced. The...
14.
Okazaki M, Sahashi Y, Nagase T, Inoue K, Sekiguchi Y, Nitta J, et al.
Pacing Clin Electrophysiol
. 2023 Nov;
47(1):131-138.
PMID: 38010718
Background: Subcutaneous implantable cardioverter defibrillators (S-ICDs) are occasionally used in combination with other cardiac implantable electronic devices (CIEDs). However, whether the incidence of inappropriate shock increases in patients with S-ICDs...
15.
Miyazaki S, Kobori A, Jo H, Keida T, Yoshitani K, Mukai M, et al.
Front Cardiovasc Med
. 2023 Nov;
10:1278603.
PMID: 37965084
Background: Symptomatic gastric hypomotility (SGH) is a rare but major complication of atrial fibrillation (AF) ablation, but data on this are scarce. Objective: We compared the clinical course of SGH...
16.
Shigeta T, Miyazaki S, Inaba O, Inamura Y, Nitta J, Sekiguchi Y, et al.
Clin Cardiol
. 2023 Oct;
47(1):e24164.
PMID: 37822107
Background: A left atrial posterior wall isolation (LAPWI) is one of the atrial fibrillation (AF) ablation strategies. Hypothesis: We hypothesized that an additional empirical LAPWI would increase the freedom from...
17.
Miyata M, Hirabayashi Y, Munakata Y, Urata Y, Saito K, Okuno H, et al.
Fukushima J Med Sci
. 2023 Mar;
69(1):11-20.
PMID: 36990790
Objectives: Methotrexate (MTX) is associated with extensive side effects, including myelosuppression, interstitial pneumonia, and infection. It is, therefore, critical to establish whether its administration is required after achieving remission with...
18.
Miyazaki S, Kobori A, Jo H, Keida T, Yoshitani K, Mukai M, et al.
Circ Arrhythm Electrophysiol
. 2023 Feb;
16(3):e011605.
PMID: 36745559
No abstract available.
19.
Fukunaga H, Inoue K, Sekiguchi Y, Nitta J, Isobe M
J Arrhythm
. 2023 Feb;
39(1):74-77.
PMID: 36733326
No abstract available.
20.
Ono K, Iwasaki Y, Akao M, Ikeda T, Ishii K, Inden Y, et al.
J Arrhythm
. 2022 Dec;
38(6):833-973.
PMID: 36524037
No abstract available.